Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
Emmanuel Velazquez-Alvarez, Product Manager at Technoclone, shared a post on LinkedIn:
“Diagnostics is indeed a very dynamic area, with significant advances in automation, assay sensitivity, and data integration.
From my perspective, one of the main challenges remains translating technological innovation into routine clinical workflows.
Factors such as standardization across laboratories, regulatory requirements, cost effectiveness, and clinician familiarity can often slow adoption despite clear technical benefits.
Bridging that gap while maintaining diagnostic accuracy and supporting faster clinical decisions will continue to be a key focus for the field.
It was inspiring to meet and exchange ideas with colleagues, researchers, clinicians, and leading experts from around the world who are shaping the future of thrombosis, hemostasis, and healthcare innovation.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia
-
Jul 21, 2026, 12:34Jim Hoffman: Separating Evidence from Misinformation on Vaccine-Associated Thrombosis